Last reviewed · How we verify

NCT05790954

The Effect of Pre-Cesarean Section Guided Imagery

Completed NA Last updated 22 February 2024
What this trial tests

NA trial testing Guided imagery in Cesarean Section in 60 participants. Completed in 31 May 2023.

Timeline
27 March 2023
Primary endpoint
31 May 2023
31 May 2023

Quick facts

Lead sponsorMenekşe Nazlı AKER
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date27 March 2023
Primary completion31 May 2023
Estimated completion31 May 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Menekşe Nazlı AKER

Who can join

18 and older, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effect of guided imagery applied before cesarean section on preoperative anxiety, fear and physiological parameters. The study will be carried out in two different groups. The practice will start with meeting the women 3 days before cesarean section. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out random. The following applications will be made to the groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Guided imagery

Trials testing the same drug.

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other Menekşe Nazlı AKER trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05790954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing